Home/Pipeline/Theta 3-D Sequencer

Theta 3-D Sequencer

N/A (Instrument Platform)

Development / Early AccessActive

Key Facts

Indication
N/A (Instrument Platform)
Phase
Development / Early Access
Status
Active
Company

About Single Technologies

Single Technologies is pioneering a paradigm shift in next-generation sequencing (NGS) with its 3-D Sequencing™ platform, which moves from a flat flow cell to a three-dimensional cube structure. This architectural innovation is designed to break the throughput plateau of conventional NGS by enabling massively parallel DNA reading, while inherently combining sequencing data with spatial context. The company is developing its first product, Theta, as a 3-D Sequencer for short-read applications and is engaging with early-access partners to build novel applications in genomics, proteomics, and spatial biology. As a private, pre-revenue platform company, Single Technologies' success hinges on validating its core technology and translating its theoretical performance advantages into a commercial instrument.

View full company profile